BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27846740)

  • 1. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis.
    Puustinen L; Boyd S; Mustonen H; Arkkila P; Arola J; Färkkilä M
    Scand J Gastroenterol; 2017 Mar; 52(3):321-327. PubMed ID: 27846740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study.
    Borssén ÅD; Palmqvist R; Kechagias S; Marschall HU; Bergquist A; Rorsman F; Weiland O; Verbaan H; Nyhlin N; Nilsson E; Werner M
    Medicine (Baltimore); 2017 Aug; 96(34):e7708. PubMed ID: 28834875
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Puustinen L; Hakkarainen A; Kivisaari R; Boyd S; Nieminen U; Färkkilä M; Lundbom N; Arkkila P
    Scand J Gastroenterol; 2017 Aug; 52(8):886-892. PubMed ID: 28415898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Dhaliwal HK; Hoeroldt BS; Dube AK; McFarlane E; Underwood JC; Karajeh MA; Gleeson D
    Am J Gastroenterol; 2015 Jul; 110(7):993-9. PubMed ID: 26010310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of liver biopsy in the diagnosis of autoimmune hepatitis].
    Szabó Z
    Orv Hetil; 2006 Sep; 147(35):1697-702. PubMed ID: 17051746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of fibrosis in chronic hepatitis C.
    Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
    Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Wang H; Xu H; Qu L; Wang X; Wu R; Gao X; Jin Q; Niu J
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):997-1002. PubMed ID: 27167453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
    Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amount of liver tissue is essential for accurate histological staging in patients with autoimmune hepatitis.
    Vetter M; Kremer AE; Agaimy A; Konturek PC; Pfeifer L; Neurath MF; Siebler J; Zopf S
    J Physiol Pharmacol; 2021 Feb; 72(1):. PubMed ID: 34272349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Marcolongo M; Young B; Dal Pero F; Fattovich G; Peraro L; Guido M; Sebastiani G; Palù G; Alberti A
    Hepatology; 2009 Oct; 50(4):1038-44. PubMed ID: 19676127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients.
    Nguyen Canh H; Harada K; Ouchi H; Sato Y; Tsuneyama K; Kage M; Nakano M; Yoshizawa K; Takahashi A; Abe M; Kang JH; Koike K; Inui A; Fujisawa T; Takaki A; Arinaga-Hino T; Torimura T; Suzuki Y; Fujiwara K; Zeniya M; Ohira H; Tanaka A; Takikawa H;
    J Clin Pathol; 2017 Nov; 70(11):961-969. PubMed ID: 28428284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy.
    Cotler SJ; Jakate S; Jensen DM
    J Clin Gastroenterol; 2001; 32(5):428-30. PubMed ID: 11319316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustic Radiation Force Impulse (ARFI) for Fibrosis Staging in Patients with Autoimmune Hepatitis.
    Efe C; Gungoren MS; Ozaslan E; Akbiyik F; Kav T
    Hepatogastroenterology; 2015 May; 62(139):670-2. PubMed ID: 26897951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis?
    Duclos-Vallée JC; Yilmaz F; Johanet C; Roque-Afonso AM; Gigou M; Trichet C; Féray C; Ballot E; Dussaix E; Castaing D; Bismuth H; Samuel D; Guettier C
    Clin Transplant; 2005 Oct; 19(5):591-9. PubMed ID: 16146549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation.
    Manousou P; Burroughs AK; Tsochatzis E; Isgro G; Hall A; Green A; Calvaruso V; Ma GL; Gale J; Burgess G; O'Beirne J; Patch D; Thorburn D; Leandro G; Dhillon AP
    J Hepatol; 2013 May; 58(5):962-8. PubMed ID: 23262247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
    J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.